Assuntos
Oral GLP-1

News (EN)
Eli Lilly Wins FDA Approval for Foundayo Daily Obesity Pill
The American regulatory agency approved the pharmaceutical company's oral medicine Eli Lilly for adults with obesity or overweight associated with…
Últimas Notícias
Novo Nordisk projects oral weight-loss drugs to exceed a third of GLP-1 market by 2030 amid consumer shifts
Oral weight-loss medications are now projected to capture a third or more of the global GLP-1 market by 2030, a significantly higher percentage than…
News (EN)
